A detailed history of Omers Administration Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Omers Administration Corp holds 13,900 shares of EXEL stock, worth $462,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,900
Previous 12,700 9.45%
Holding current value
$462,731
Previous $285,000 26.32%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$21.96 - $27.6 $26,352 - $33,120
1,200 Added 9.45%
13,900 $360,000
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $315,270 - $367,815
-15,500 Reduced 54.96%
12,700 $285,000
Q4 2023

Feb 13, 2024

BUY
$19.25 - $24.13 $542,850 - $680,466
28,200 New
28,200 $676,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.